Analysis of the balance between proliferation and apoptosis of cultured vascular smooth muscle cells for tissue-engineering applications

Tissue Engineering

Volumn 11, Issue 11-12, 2005, Pages 1631-1639

  Engbers Buijtenhuijs, P ^a,b   Buttafoco, L ^a   Poot, A A ^a   Geelkerken, R H ^b   Feijen, J ^a   Vermes, I ^a,b  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; BIOMARKERS; CELL CULTURE; ENZYMES; GENETIC ENGINEERING; MUSCLE; OPTICAL MICROSCOPY; POLYSTYRENES; RNA; TUMORS;

APOPTOSIS; TISSUE ENGINEERING;

TISSUE CULTURE;

BIOLOGICAL MARKER; COLLAGEN; CYCLIN E; CYCLOHEXIMIDE; DNA FRAGMENT; ELASTIN; GELATIN; LIPOCORTIN 5; MESSENGER RNA; POLYSTYRENE; PORPHOBILINOGEN DEAMINASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

ANALYTIC METHOD; APOPTOSIS; ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROSCOPY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TISSUE ENGINEERING; VASCULAR SMOOTH MUSCLE;

ANNEXIN A5; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN E; DNA FRAGMENTATION; HUMANS; MYOCYTES, SMOOTH MUSCLE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ENGINEERING; TRANSGLUTAMINASES; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 31044449868     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2005.11.1631     Document Type: Article

References (30)

1. Vermeulen, K., Berneman, Z.N., and Van Bockstaele, D.R. Cell cycle and apoptosis. Cell Prolif. 36, 165, 2003.
2. Vermes, I., Haanen, C., and Reutelingsperger, C. Flow cytometry of apoptotic cell death. J. Immunol. Methods 243, 167, 2000.
3. Darzynkiewicz, Z., Bedner, E., and Smolewski, P. Flow cytometry in analysis of cell cycle and apoptosis. Semin. Hematol. 38, 179, 2001.
4. Michie, J., Akudugu, J., Binder, A., Van Rensburg, C.E.J., and Bohm, L. Flow cytometric evaluation of apoptosis and cell viability as a criterion of anti-tumour drug toxicity. Anticancer Res. 23, 2675, 2003.
5. Micoud, F., Mandrand, B., and Malcus-Vocanson, C. Comparison of several techniques for the detection of apoptotic astrocytes in vitro. Cell Prolif. 34, 99, 2001.
6. van Engeland, M., Ramakers, F.C.S., Schutte, B., and Reutelingsperger, C.P.M. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 24, 131, 1996.
7. Fesus, L., and Piacentini, M. Transglutaminase 2: An enigmatic enzyme with diverse functions. Trends Biochem. Sci. 27, 534, 2002.
8. Melino, G., Candi, E., and Steiner, P.M. Assays for transglutaminases in cell death. Methods Enzymol. 322, 433, 2000.
9. Volokhina, E.B., Hulshof, R., Haanen, C., and Vermes, I. Tissue transglutaminase mRNA expression in apoptotic cell death, Apoptosis 8, 679, 2003.
10. Heid, C.A., Stevens, J., Livak, K.J., and Williams, P.M. Real time quantitative PCR. Genome Res. 6, 986, 1996.
11. Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grinani, F., and Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139, 271, 1991.
12. Engbers-Buijtenhuijs, P., Kamphuis, M., van der Sluijs Veer, G., Haanen, C., Poot, A.A., Feijen, F., and Vermes, I. A novel time-resolved fluorometric assay of anoikis using europium-labelled annexin V in cultured adherent cells. Apoptosis 10, 429, 2004.
13. 1-to-S phase transition. Mol. Cell. Biol. 15, 2612, 1995.
14. Muller-Tidow, C., Metzger, R., Kugler, K., Diederichs, S., Idos, G., Thomas, M., Dockhorn-Dworniczak, B., Schneider, P.M., Koeffler, H.P., Berdel, W.E., and Serve, H. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Cancer Res. 61, 647, 2001.
15. Buijtenhuijs, P., Buttafoco, L., Poot, A.A., Daamen, W.F., van Kuppevelt, T.H., Dijkstra, P.J., de Vos, R.A.I., Sterk, L.M.T., Geelkerken, R.H., Feijen, F., and Vermes, I. Tissue engineering of blood vessels: Characterisation of smooth muscle cells for culturing on collagen and elastin based scaffolds. Biotechnol. Appl. Biochem. 39, 141, 2003.
16. Daamen, W., Veerkamp, J.H., and van Kuppevel, T.H. Purification of elastin and preparation of matrices for tissue engineering. Ind. Protein 9, 15, 2001.
17. Heimli, H., Kahler, H., Endresen, M.J., Henriksen, T., and Lyberg, T. A new method for isolation of smooth muscle cells from human umbilical cord arteries. Scand. J. Clin. Lab. Invest. 57, 21, 1997.
18. Chamley-Campbell, J., Campbell, G.R., and Ross, R. The smooth muscle cell in culture. Physiol. Rev. 59, 1, 1979.
19. Lefebvre, P., Nusgens, B.V., and Lapiere, C.M. Cultured myofibroblasts display a specific phenotype that differentiates them from fibroblasts and smooth muscle cells. Dermatology 189, 65, 1994.
20. Salgame, P., Varadhachary, A.S., Primiano, L.L., Fincke, J.E., Muller, S., and Monestier, M. An ELISA for detection of apoptosis. Nucleic Acids Res. 25, 680, 1997.
21. Hemmilä, I., Dakabu, S., and Mukkala, V.M., Siitari, H., and Lovgren, T. Europium as a label in time-resolved immunofluorometric assays. Anal. Biochem. 137, 335, 1984.
22. Jones, L.J., Gray, M., Yue, S. T., Haugland, R. P., and Singer, V. L., Sensitive determination of cell number using the CyQuant cell proliferation assay. J. Immunol. Methods 254, 85, 2001.
23. Olde Damink, L.H.H., Dijkstra, P.J., van Luyn, M.J.A., van Wachem, P.B., Nieuwenhuis, P., and Feijen, J. Purification of elastin and preparation of matrices for tissue engineering. Ind. Protein 9, 15, 2001.
24. Li, Y., Ma, T., Kniss, D.A., Lasky, L.C., and Yang, S. Effects of filtration seeding on cell density, spatial distribution, and proliferation in nonwoven fibrous matrices. Biotechnol. Prog. 17, 935, 2001.
25. Smolewski, P., Grabarek, J., Lee, B.W., Johnson, G.L., and Darzynkiewicz, Z. Kinetics of HL-60 cell entry to apoptosis during treatment with TNF-α or camptothecin assayed by the stathmo-apoptosis method. Cytometry 47, 143, 2002.
26. Pelisek, J., Armeanu, S., and Nikol, S. Quiscence, cell viability, apoptosis and necrosis of smooth muscle cells using different growth inhibitors. Cell Prolif. 34, 305, 2001.
27. Keyomarsi, K., Tucker, S.L., Buchholz, T.A., Callister, M., Ding, Y., Horogagyi, G.N., Bedrosian, L, Knickerbocker, C., Toyofuku, W., Lowe, M., Herliczek, T.W., and Bacus, S.S. Cyclin E and survival in patients with breast cancer. N. Engl. J. Med. 347, 1566, 2002.
28. Sutherland, R.L., and Musgrove, E.A. Cyclin E and prognosis in patients with breast cancer. N. Engl. J. Med. 347, 1546, 2002.
29. Evan, G.I., and Vousden, K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342, 2001.
30. Seliktar, D., Nerem, R.M., and Galis, Z.S. Mechanical strain-stimulated remodeling of tissue-engineered blood vessel constructs. Tissue Eng. 9, 657, 2003.